Concepedia

Richard Rampulla

RR

Statistics

Publications

25

Citations

878

H-Index

18

Active since

1988

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Bristol-Myers Squibb (India)

Syngene International (India)

Johnson & Johnson (United States)

Richard Rampulla is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

Publications per year

1988–2021

25

Publications

25

Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents

Ronald K. Russell, Jeffery B. Press, Richard Rampulla et al. · Journal of Medicinal Chemistry · 1988 · 176 citations

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)

Scott H. Watterson, Qingjie Liu, Myra Beaudoin Bertrand et al. · Journal of Medicinal Chemistry · 2019 · 104 citations · Full text

, , +20

Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors

Ashvinikumar V. Gavai, Claude Quesnelle, Derek Norris et al. · ACS Medicinal Chemistry Letters · 2015 · 88 citations · Full text

, , +18

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Ashvinikumar V. Gavai, Derek Norris, George V. Delucca et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor

Barbara Zheng, Stanley V. D’Andrea, Li‐Qiang Sun et al. · ACS Medicinal Chemistry Letters · 2018 · 38 citations · Full text

Rows per page

1–5 of 25